ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 168516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 168516; 2) Community: the network communities that were significantly associated with the response to NSC 168516; 3) Molecule: the relationships between components within communities and NSC 168516; 4) MDR: the compounds that were significantly associated with the NSC 168516.

NSC Compound Enrichment Correlation
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0295480456086947 0.42428255
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0295480456086947 0.22282168
NSC 757795 BERBERINE CHLORIDE 0.0295480456086947 0.15040361
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0295480456086947 0.55078333
NSC 762009 Copper(II) complex with quin as a ligand 0.0295480456086947 0.23758274
NSC 763232 Null 0.0295480456086947 0.23063436
NSC 763564 EMD-534085 0.0295480456086947 0.45722827
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.0295480456086947 0.28527446
NSC 87500 Solacongestidine 0.0295480456086947 0.33922666
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0314734733353265 0.21268087
Total:118  Current:92    [First] [Prev] [Next] [Last]